Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1025 | 1026 | (Page 1027) | 1028 | 1029 | .... | 1118 | newer

    0 0

    (EMAILWIRE.COM, April 29, 2018 ) Healthcare Cloud Computing is process of storing, managing, and processing the data, collected from various locations and delivering the required services through internet. The cloud computing technology in healthcare industry in basically used for memory, computation, networking, and storage purposes. The healthcare cloud computing companies offers services such as Software-As-A-Service (SAAS), Platform-As-A-Service (PAAS), and Infrastructure-As-A-Service (IAAS). These services can be deployed in public cloud, private cloud, and hybrid cloud.

    For more information about this report visit: https://tinyurl.com/y7p7g5x7

    Growing demand of cloud for improving storage, scalability, & flexibility of data and increasing implementation of information technology for cloud adoption and reduction in healthcare costs are the major drivers which are likely to anticipate the growth of healthcare cloud computing market. Technological advancements & proliferation of internet and favorable regulatory acts are likely to add new opportunities for this market in the coming years.

    The “Global Healthcare Cloud Computing Market Analysis to 2025” is a specialized and in-depth study of the healthcare cloud computing industry with a focus on the global market trend. The report aims to provide an overview of global healthcare cloud computing market with detailed market segmentation by service, deployment mode, application, and geography. The global healthcare cloud computing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global healthcare cloud computing market based on service, deployment mode, and application. It also provides market size and forecast till 2025 for overall healthcare cloud computing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The report also includes the profiles of key healthcare cloud computing manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Global Net Access (GNAX), Carecloud Corporation, Dell Inc., Athenahealth, Inc., Carestream Health, Inc., VMWare, Inc., Iron Mountain, Inc., IBM Corporation, Cleardata Networks, Inc., and Merge Healthcare, Inc. among others.


    Sameer Joshi
    +91 9666111581
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, April 30, 2018 ) Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Vulvar Cancer - Pipeline Review, H1 2017, provides an overview of the Vulvar Cancer (Oncology) pipeline landscape.

    Vulvar cancer is a rare type of cancer. It forms in a woman's external genitals, called the vulva. The cancer usually develops slowly over several years. First, precancerous cells grow on vulvar skin. This is called vulvar intraepithelial neoplasia (VIN) , or dysplasia. Not all VIN cases turn into cancer, but it is best to treat it early.

    Get Expert PDF Sample on Vulvar Cancer: http://www.reportsweb.com/inquiry&RW0001834370/sample

    Report Highlights
    Publisher's Pharmaceutical and Healthcare latest pipeline guide Vulvar Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Vulvar Cancer (Oncology) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Vulvar Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Vulvar Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II stages are 5 respectively.

    Vulvar Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Buy Report@ http://www.reportsweb.com/buy&RW0001834370/buy/2000

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Vulvar Cancer (Oncology) .
    - The pipeline guide reviews pipeline therapeutics for Vulvar Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Vulvar Cancer (Oncology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Vulvar Cancer (Oncology) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Vulvar Cancer (Oncology)

    Reasons to buy
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Vulvar Cancer (Oncology) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Vulvar Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Discount Inquiry@ http://www.reportsweb.com/inquiry&RW0001834370/discount


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, April 30, 2018 ) Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

    Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share. United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.

    Get Sample Copy@ http://www.reportsweb.com/inquiry&RW0001428680/sample

    Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France. Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.

    The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.

    The 10 countries covered in the report are analysed from two viewpoints:
    1. Number of Kidney Transplant Performed (2008 - 2021)
    2. Kidney Transplant Market (2008 - 2021)


    Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:
    1. United States
    2. Germany
    3. France
    4. Italy
    5. United Kingdom
    6. Japan
    7. Argentina
    8. Mexico
    9. Spain
    10. Brazil

    Inquiry for Report@ http://www.reportsweb.com/inquiry&RW0001428680/buying

    Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows
    1. Cellcept (Mycophenolate Mofetil)
    2. Prograf(Tacrolimus)
    3. Rapamune (Sirolimus)
    4. Myfortic (Mycophenolic Acid)
    5. Neoral / Sandimmune (Cyclosporine)
    6. Zortress / Certican (Everolimus)


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. The key factors propelling the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-prosthetic-heart-valve-artificial-heart-valve-market-analysis-and-forecast-to-2022-growth/6795137

    In this report, the prosthetic heart valve market has been segmented based on the type of valve and region. On the basis of the type of valve, the market is segmented into transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to command the largest share of the global market in 2017 and is expected to register the highest CAGR of 18.0% during the forecast period. The large share and high growth rate of this segment can be attributed to the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements. The preference for transcatheter heart valves is expected to witness high growth in the future as they are implanted through a minimally invasive procedure while the other valve types require open-heart surgery.

    Request free sample @ https://www.researchcosmos.com/request/6795137

    In 2017, North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the RoW. North America is also expected to register the highest CAGR during the forecast period. The large share and high growth in this regional segment can be attributed to factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valve market.

    A majority of the leading players in this market are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities. Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), and St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.) are identified as the top players in this market. These companies have a diversified product portfolio, wide geographic reach, and a strong focus on innovation and research.

    Check for discount @ https://www.researchcosmos.com/discount/6795137

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1%. The increasing pharmaceutical & biotech R&D expenditure and the favorable government funding scenario for proteomics research are the major factors that are expected to drive the growth of the market during the forecast period.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-protein-assays-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/3765257

    The global protein assays market is segmented based on type, product, technology, application, end user, and region. The market, on the basis of type, is segmented into dye-binding assays, copper-ion based assays, test strip-based assays, and other protein assays. In 2017, the dye-binding assays segment is expected to account for the largest share of the market. This growth can be attributed to the increasing usage of dye-binding assays in disease diagnosis.

    The protein assays market, based on technology is segmented into absorbance-based assays, colorimetric protein assays, and fluorescence-based protein assays. In 2017, the absorbance-based protein assays segment is expected to account for the largest share of the market. The growth in this segment can primarily be attributed to the increasing sensitivity and accuracy of absorbance-based protein assays owing to the advent of new techniques.

    The protein assays market, by product, is segmented into reagents, kits, and instruments & accessories. In 2017, the reagents segment is expected to account for the largest share of this market.

    Request free sample @ https://www.researchcosmos.com/request/3765257

    The protein assays market, by application, is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of protein assays used to diagnose cancer; immune system diseases; and liver, kidney, and bone marrow diseases.

    On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The growth in this segment can primarily be attributed to the increasing drug development in the life science industry.

    Based on region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the increasing R&D expenditure in life science, and increasing private-public partnerships for proteomics research are some major factors driving the growth of this regional segment.

    Key players operating in the protein assays market include Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).

    Check for discount @ https://www.researchcosmos.com/discount/3765257

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) Ophthalmic devices are medical devices utilized in identity and treatment of ocular defects and eye issues. The increasing occurrence of eye disorders and imaginative and prescient loss are pushing the demand for ophthalmic devices worldwide. Ophthalmology is a branch of medical sciences that deals with the shape, characteristics, and numerous eye illnesses. The ophthalmic devices are a scientific device designed for prognosis, surgical, and vision correction purposes. These devices gain extended significance and adoption due to the high occurrence of various ophthalmic diseases inclusive of glaucoma, cataract, and different vision associated problems.

    The ophthalmology field requires medical devices for numerous functions which include analysis, imaginative and prescient care, and surgery. The development of modern devices and growing software technology in ophthalmology has paved way for customers to have realistic and affordable solutions for numerous eye-related disorders together with vitreoretinal disorders, refractor disorders, and cataract.

    According to WHO, an expected 253 million humans live with prescient impairment issues, out of which 36 million are blind and 217 million have moderate to extreme vision impairment. Cataract is responsible for 48% of the population turning into absolutely blind. Further, extra than 60 million human beings suffer from glaucoma and this wide variety is predicted to attain 80 million by using 2020. Increasing old population is also ensuing in more human beings tormented by refractive errors.

    View sample and decide: https://www.marketdataforecast.com/market-reports/north-america-ophthalmic-devices-market-1748/request-sample

    North America Ophthalmic devices market was worth $ 11.26 billion in 2016 and anticipated to be developing at a CAGR of 5.8 %, to reach $ 14.93 billion by 2021.

    Drivers and Restraints:
    One of the primary factors of the upward trend in the ophthalmic device's market is the growing geriatric population. It is discovered that the elderly are extra at risk of developing eye-associated issues, rising frequency of normal existence related diseases, developing relevance of era in ophthalmology, consisting of glaucoma and dry eye, and are the target customers of ophthalmic device producers.

    However, an excessive cost of a few gadgets, in particular, the ones which might be exported. Additionally, the shortage of skilled experts, especially in the rural regions of rising economies, is another high problem for manufacturers are hampering the market growth.

    To know more read: https://www.marketdataforecast.com/market-reports/north-america-ophthalmic-devices-market-1748/

    Geographic Segmentation
    Based on North America geography the market is segmented into numerous areas specifically US and Canada. Among North American international locations in 2011, the U.S. held the largest share of the market for ophthalmic devices across all segments. The western country markets are experiencing rigorous competition due to mushrooming local manufacturers at the same time as outstanding gamers with better marketplace penetration levels, who are focusing extra on gadgets with diagnosis and surgical operation applications.

    Get your customized report: https://www.marketdataforecast.com/market-reports/north-america-ophthalmic-devices-market-1748/customize-report

    The key players of the market include Alcon Inc., Essilor International S.A., Johnson & Johnson, Abbott Medical Optics Inc., Bausch & Lomb, Inc., Haag-Streit AG, Topcon Corporation, Carl Zeiss Meditec AG, Nidek Co. Ltd., and Ziemer Ophthalmic Systems AG.

    Scope of the report
    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.



    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis.

    The pulmonary drug delivery market is segmented based on formulations, canister type, applications, end users, and regions. The formulation segment is further divided into device type and formulation type.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-pulmonary-respiratory-drug-delivery-market-analysis-and-forecast-to-2022-growth-opportunit/2978801

    The respiratory drug delivery market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The metered dose inhalers segment is expected to account for the largest share of the market by type of delivery by device, in 2016. Factors such as the efficient absorption of drugs through the lungs and negligible side effects (as drugs are exposed only to the lungs) are contributing to the growth of this segment.

    The pulmonary drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

    Based on canister type, the respiratory drug delivery market is segmented into plain canisters and coated canisters. The plain canisters segment is expected to command the largest share of the pulmonary drug delivery devices market in 2016. The market for these canisters is majorly driven by the rising incidence of COPD and increasing use of inhalers

    Request free sample @ https://www.researchcosmos.com/request/2978801

    Based on end user, the pulmonary drug delivery market is segmented into hospitals & clinics and home care settings. In 2016, the home care settings segment is expected to grow at a highest CAGR of the market due to technological advancements such as digital inhalers in pulmonary drug delivery devices that enable their usage in the home care settings.

    Presently, North America dominates the pulmonary drug delivery market, and Europe represents the second-largest regional market.  This is attributed to increasing technological developments in the form of digital inhalers developed by various companies and supportive reimbursement policies in the form of Medicare and Medicaid.

    Prominent players in the respiratory drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

    Check for discount @ https://www.researchcosmos.com/discount/2978801

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) Protein expression is a technique or methodology in which proteins are characterized, modified, and synthesized in the host cells. The selected protein is typically achieved by the modification or alteration of the protein expression process in a living cell. Various kinds of protein expression systems are used for the production of a broad range of therapeutic proteins such as insulin, interferons, and interleukins. The global market is expected to reach USD 2.850.5 Million by 2022 from USD 1,654.0 Million in 2017, at a CAGR of 11.5% during the forecast period.  The rising prevalence of chronic disorders disease, the growing number of life sciences and biopharmaceutical industries, rising research activities on recombinant-based protein expression and technological advancements in protein expression systems are the major driving factors for this market.

    The protein expression systems market is segmented on the basis of systems type, product, application and end user. On the basis of systems type, the market is segmented into insect cell expression systems; mammalian cell expression systems; prokaryotic expression systems, yeast expression systems; cell-free expression systems; and algal-based expression systems. The prokaryotic expression systems segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to the frequent use of prokaryotic protein expression systems as they are cheaper compared to other expression systems.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-protein-expression-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6366719

    On the basis of product, the market is segmented into competent cells, expression vectors, instruments, reagents, and services. The reagents segment is expected to hold the largest market share of the protein expression market. This is primarily due to the increasing protein expression research activities and the large-scale production of antibodies and vaccines.

    By application, the protein expression market is segmented into therapeutic applications, research applications and industrial applications. The therapeutic applications segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to increasing prevalence of chronic diseases such as cancer and diabetes around the world.

    Request free sample @ https://www.researchcosmos.com/request/6366719

    Based on end user, the market has been segmented into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry). The pharmaceutical and biotechnology companies segment is expected to dominate the market during the forecast period, owing to technological advancement in protein expression research and the rising production of recombinant therapeutic proteins for disease treatment.

    By region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe. However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; rising prevalence of chronic diseases are some of the key factors driving the high growth of this regional segment.

    The high cost of protein expression instruments & reagents and increasing consolidation in the protein expression are the restraining factors for this market.

    Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Takara Bio Inc. (Japan), Promega Corporation (U.S.), Genscript Biotech Corporation (China), and Agilent Technologies Inc. (U.S.) are the top six players in this market. These companies have a broad product portfolio with comprehensive features and have a strong geographical presence. Further, these leaders cater to the requirements of major end users such as research laboratories and pharmaceutical & biotechnology companies.

    Check for discount @ https://www.researchcosmos.com/discount/6366719

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) Muscle stimulation is a way that utilizes electrical impulses as a remedy at the muscle for relieving the continual ache. This approach utilizes transcutaneous electrical nerve stimulator (TENS), burst mode alternating modern (BMAC), interferential (IF) and neuromuscular electric stimulation (NMES) modalities. These devices are widely used for the remedy of persistent ache in the leg and returned. Muscle stimulation gadgets are especially utilized by sufferers suffering from persistent pain and with the aid of athletes for easing muscle pain.

    Maximum Muscle stimulators which have been accredited by the FDA are used for the cause of physiotherapy of an affected person after a harm or rehabilitation below the path of a medical expert.

    Muscle stimulators while used without the presence of a clinical expert can bring about shocks, burns, bruising and pores and skin irritation consequently the authorities have imposed strict regulations regarding using such electrical muscle stimulators. Using electrical muscle stimulators have been very famous among sports activities scientists as it compliments sports activities schooling.

    According to World Health Organization by 2050, the world’s populace aged 60 years and older is predicted to overall reach a figure of 2 billion, up from 900 million in 2015. The arena health agency also estimates that nowadays, 125 million people are elderly 80 years or older.

    View sample and decide: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-muscle-stimulation-devices-market-5281/request-sample

    Drivers and Restraints:

    With the introduction of new revolutionary technology, fitness attention among aged people, healthcare budgets growth and advance therapies in sports activities remedy, the muscle simulator market is all set to increase at some stage in the coming decade. Growing healthcare expenditure and growing demand for continual pain control are key elements using call for. Developing preference for muscle stimulation devices among physiotherapists and increasing incidence of weight problems are other fundamental factors responsible for the growth of the market.

    Although the market is expected to witness tremendous boom over the forecast period, low awareness concerning available treatment options for continual diseases and possible electrotherapy remedy modalities can hinder the growth of the market.

    To know more read: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-muscle-stimulation-devices-market-5281/

    Geographic Segmentation

    On the premise of areas, the Middle East and Africa muscle stimulation devices market have been segmented into Middle East and Africa (MEA). The main factors responsible for the growth of the market in this vicinity are upward push in geriatric populace base, growing demand for superior clinical and surgical interventions.

    Get your customized report: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-muscle-stimulation-devices-market-5281/customize-report

    The leading companies of the market include DJO Middle East and Africa, Inc., Zynex, Inc., Neuro Metrix, Inc., RS Medical, Inc. and Omron Corp.



    Scope of the report

    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

    About Market Data Forecast
    Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) A genetic test is an analysis of a part of your DNA. It can help to decide if there's an alternate in a selected gene or chromosome. The exchange often referred to as mutation, might also affect all the cells inside the organism and be transmissible to future generations. Genetic testing for diseases is a trendy market, particularly in the United Kingdom and U.S.
    Genetics offerings in the NHS had been first established 50 years ago, however our information of the genetic basis of sickness has elevated dramatically in recent years. The human genome became sequenced in 2003 and in a white paper published in the same year, the authorities mentioned a imaginative and prescient for the NHS to be an international leader in genetics-based healthcare and set apart £50m funding over 3 years to enhance diagnosis and trying out facilities and finance research projects.

    There are 22 local genetics centers within the United Kingdom. DNA molecular exams are supplied for about 300 rare single gene problems at the NHS. But, approximately 6,000 single-gene problems were recognized. Single-gene issues, along with cystic fibrosis, have an effect on between 1-5% of the populace and price the NHS and social services about £2bn a year. There are also genetic assessments for familial risk of certain disorders. For instance, the BRCA1 gene can increase a lifetime hazard of breast most cancers by using 35-80%.

    View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-genetic-testing-market-39/request-sample
    The Asia-Pacific Genetic testing market was estimated to be $7.502 million in 2015 and is forecasted to attain $10.845 Million through 2020, growing at a CAGR of 7.65%.

    Drivers and Restraints:
    The prominent factors such as growing incidences of hereditary and genetically predisposed diseases, unexpectedly incrementing percent of the geriatric population, growing recognition concerning the genetic testing services some of the urban populations, technological advancements, and established fulfillment of direct-to-purchaser (DTC) genetic testing. Some of financially system agencies have invested in the studies and development as a way to widen the scope of genetic testing, which allows you to further raise the demand for genome sequencing technologies. The market for genetic testing is also expected to benefit traction from growing prevalence of cancer, converting demographical and lifestyle, a complex interplay of environmental factors, and inclined genes.

    However, excessive cost worried, lack of skilled professionals and stringent guidelines in a few regions are restraining the genetic testing marketplace.

    To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-genetic-testing-market-39/

    Geographic Segmentation
    Furthermore, on the idea of geography, the Asia-Pacific market is analyzed underneath diverse regions namely, India, China, Japan, and South Korea. Asia Pacific is anticipated to achieve a high growth rate within the following couple of years in genetic testing marketplace. China and Japan are anticipated to be the quickest developing genetic testing markets in Asian place.

    Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-genetic-testing-market-39/customize-report

    Some of the main companies of the market include Abbott Laboratories, Roche Molecular Diagnostics Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc. and Applied Biosystems Inc.

    Scope of the report
    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 Million by 2022 from USD 161.3 Million in 2017. This market is mainly driven by the increasing needs to cut radiation dose levels causing chronic diseases, need for regulatory compliance, and need for improved patient safety and for accurate and reliable systems to manage critical radiation dose levels and information. Moreover, the safe and ensured environment through radiation dose management systems results in a streamlined workflow, thus increasing the operational efficiency and quality of healthcare organizations. However, lack of funding and lack of standardized protocols for radiation dose management are expected to restrain the growth of this market to a certain extent in the developing regions.

    Explore More Information about report @ hhttps://www.researchcosmos.com/reports/global-radiation-dose-management-market-analysis-and-forecast-to-2022-growth-opportunity-assessmen/1341861

    The global market is segmented on the basis of products & services, modality, end user, and region. On the basis of products and services, the market is segmented into solutions and services. The solutions market is further subdivided into standalone solutions and integrated solutions. The services market is subdivided into implementation and integration services, support and maintenance services, consulting services, and education and training services. By modality, the market is divided into computed tomography, fluoroscopy and interventional imaging, radiography & mammography, and nuclear medicine. The market is further segmented by end users into hospitals, ambulatory care settings, and research institutions and academic medical centers.

    Geographically, the global market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America accounted for the largest share of the global radiation dose management market, followed by Europe, Asia-Pacific, and RoW. This is due to the presence of a large number of hospitals and health systems, changing regulations, increasing accreditation requirements, and the increasing need to curtail the soaring healthcare costs.

    Request free sample @ https://www.researchcosmos.com/request/1341861

    However, the market in Europe is expected to grow at the highest CAGR during the forecast period. Government initiatives in this region to increase patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the European market. The EU directives regarding the use of ionizing radiation, which will be repealed from February 6, 2018, is a prime factor for the increasing adoption of radiation dose management solutions by healthcare providers in Europe, which in turn is driving the growth of this geographic segment during the next two years.

    The key players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.S.), PACSHealth LLC (U.S.), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.), Siemens Healthineers (Germany), AGFA Healthcare (Belgium), Sectra AB (Sweden), QAELUM N.V. (Belgium), Bracco Imaging S.p.A. (Italy), and Medsquare (France). Key players in the radiation dose management market are pursuing several organic and inorganic growth strategies such as product launches & upgrades, partnerships, collaborations & agreements, acquisitions, and expansions to garner larger shares in the market.

    Check for discount @ https://www.researchcosmos.com/discount/1341861

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global radiotherapy market is expected to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a CAGR of 6.8%. The growth of this market is majorly driven by rapidly increasing geriatric population, growing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and rising demand for radiotherapy devices.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-radiotherapy-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/9020471

    The report analyzes the global radiotherapy market by type, product type, application, end user, and region. Based on type, the external beam radiotherapy segment accounted for the largest share in 2016. The growing adoption of this therapy in emerging markets and the development of advanced external beam radiotherapy devices to localize tumorous cells while minimizing harm to surrounding healthy cells are some of the major factors contributing to the growth of this market segment.

    On the basis of product type, the electron-emitting high-energy linear accelerators segment is expected to account for the largest share of the external beam radiotherapy market in 2016. The development of advanced linear accelerators and growing adoption of these devices are some of the factors driving the growth of this market.

    On the basis of application, the prostate cancer segment held the largest share in both the internal and external beam radiotherapy markets in 2016, owing to the non-invasive nature of radiotherapy, rising incidence of prostate cancer in the geriatric male population, and high success rates achieved with radiotherapy.

    Based on end user, the hospitals segment accounted for the largest share of the global radiotherapy market in 2016. The large share of this segment can be attributed to factors such as increasing installations of advanced radiotherapy equipment in developed as well as developing regions, increasing government initiatives, and rising incidence of cancer.

    Request free sample @ https://www.researchcosmos.com/request/9020471

    This report covers the radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global radiotherapy market in 2016, followed by Europe. The large share of the North American region is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of radiotherapy products owing to the increasing incidence of cancer. The Asia-Pacific is expected to register the highest growth rate during the forecast period. Factors such as rapidly increasing aging population, growing focus of players on emerging markets, improvements in healthcare infrastructure, and rising number of new cancer cases in this region are driving the growth of the radiotherapy market in the Asia-Pacific.

    However, the underdeveloped public health infrastructure in developing nations and the shortage of trained and skilled radiation oncologists are the major factors that are expected to restrain the growth of this market.

    Varian Medical Systems (U.S.) dominates the market through its wide range of technologically advanced and innovative radiotherapy products. The company adopts the strategy of product launches and invests a significant amount of its revenue on R&D expenditure to maintain its leadership position in the market. For instance, in October 2015, the company introduced ProBeam, an upgradeable single-room proton therapy system that offers cost-effective treatment and full rotational pencil beam scanning. With its strong product portfolio and wide geographic presence, the company is expected to maintain its dominance in the market during the forecast period.

    Check for discount @ https://www.researchcosmos.com/discount/9020471

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global reaction monitoring market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%. Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and increasing public-private investments in life science research are driving the market for reaction monitoring.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-reaction-monitoring-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/4557374

    This report broadly segments the reaction monitoring market into technology, reaction mode, and end user. On the basis of technology, the market is categorized into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry. In 2017, the spectroscopy segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.

    Based on reaction mode, the market is segmented into qualitative reaction mode and quantitative reaction mode. The quantitative reaction mode segment is estimated to command the largest share of the global reaction monitoring market in 2017. The large share of this segment is mainly due to factors such as ongoing technological advancements in the field of analytical techniques (such as real-time quantification, device miniaturization, and process automation) and ongoing expansion and modernization of the pharmaceutical & biotechnology and food processing industries.

    Request free sample @ https://www.researchcosmos.com/request/4557374

    On the basis of end user, the market is segmented pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users. The pharmaceutical, biopharmaceutical, and biotechnology companies segment is projected to register the fastest rate during the forecast period. This can be attributed to the stringent regulations for pharmaceutical drug development and manufacturing (such as cGMP, cGLP, and EXCiPACT certification) and increasing usage of analytical techniques during quality assessment during drug manufacturing.

    The report covers the reaction monitoring market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017 due to the availability of private-public funding & investments for life science research, stringent regulatory framework for drug development & commercialization, effective implementation & industrial compliance with food safety regulations, rising adoption of technologically advanced pollution monitoring & control products, and growing number of clinical researches in this region. However, Asia Pacific is expected to register the highest growth rate during the forecast period. Government investments to strengthen food processing & biomedical industry in China & India; rising public emphasis on effective pollution monitoring & control (especially air pollution, water pollution, and biohazard monitoring & control); and increasing public-private funding, investments, & grants for various research activities are some of the major factors driving the growth of the Asia Pacific reaction monitoring market.

    Check for discount @ https://www.researchcosmos.com/discount/4557374

    Some of the major players operating in this market are Agilent Technologies (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US), and HORIBA (Japan).

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6% from 2016 to 2021.  This market is segmented based on types, therapy, application, and regions.

    A number of factors, such as the government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population are expected to drive the growth of this market. However, entry of new players and product failures and recalls are expected to challenge the market growth.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-regenerative-medicine-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6232121

    The global market is segmented into two types, namely, cell-based products and acellular products. The cell-based products segment is expected to account for the largest share in the global market in 2016. The increasing awareness about stem cell therapy, growing funding for new stem cell lines driving the growth of the cell-based products segment in the market.

    Based on therapy, the Regenerative medicine market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Cell therapy segment is expected to account for the largest share in the global market. The key drivers are increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.

    Request free sample @ https://www.researchcosmos.com/request/6232121

    This market is also segmented by application. By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing segment in the market due to increasing incidences of cancer globally and increasing demand for cancer treatments.

    The global Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan and India. Increasing research activities in Asian countries, availability of funding for research, and the establishment of biobanks and research centers are some factors propelling market growth.

    The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

    Check for discount @ https://www.researchcosmos.com/discount/6232121

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global rehabilitation equipment market is projected to reach USD 14.91 Billion by 2021 from USD 9.86 Billion in 2016, at a CAGR of 8.6% during the forecast period. The market is mainly driven by factors such increasing incidence of disabilities, favorable healthcare reforms, and rapid growth in the geriatric population.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-rehabilitation-equipment-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/3908193

    On the basis of type, the rehabilitation equipment market is segmented into mobility equipment, body support devices, exercise equipment, and daily living aids. In 2016, the daily living aids segment accounted for the largest share of the market. The dominance of this segment is attributed to the increasing prevalence of non-communicable diseases such as cancer and cardiovascular diseases, which need long-term treatment. However, the mobility equipment segment is expected to grow at the highest CAGR during 2016–2021.

    On the basis of application, the rehabilitation equipment market is divided into two segments physiotherapy and occupational therapy. The physiotherapy segment is projected to grow at the highest CAGR during the forecast period. The growth of this segment is majorly attributed to the increasing need for physiotherapy among the aging population & disabled patients and the implementation of favorable government policies.

    Request free sample @ https://www.researchcosmos.com/request/3908193

    On the basis of end user, the rehabilitation equipment market is segmented into hospitals & clinics, rehabilitation centers, physiotherapy centers, and home care settings. In 2016, the hospitals & clinics segment accounted for the largest share of the market. The dominance of this segment in the rehabilitation equipment market is mainly attributed to the higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments.

    The market is dominated by Europe, followed by North America, Asia, and the Rest of the World. In 2016, Europe accounted for the largest share of the global rehabilitation equipment market. North America is expected to grow at the highest CAGR during the forecast period. Factors such as growth in geriatric population and the subsequent increase in the prevalence of lifestyle diseases and the presence of favorable healthcare reforms are driving the growth of the North American rehabilitation equipment.

    Key players in the rehabilitation equipment market include Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (U.S.), and Hospital Equipment Manufacturing Company (India).

    Check for discount @ https://www.researchcosmos.com/discount/3908193

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global respiratory care devices market is projected to reach USD 24.07 Billion by 2021, at a CAGR of 9.7% from 2016 to 2021. The market growth can be attributed to a number of factors such as high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-respiratory-care-devices-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/4388298

    In this report the global respiratory care devices market is segmented on the basis of type, disease/disorder, end user and region. Based on type, the market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. The therapeutic devices segment is subsegmented into PAP devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. The monitoring devices segment is subsegmented into pulse oximeters, capnographs and gas analyzers. The diagnostic devices segment is subsegmented into spirometers, polysomnography devices (PSG), peak flow meters and other diagnostic devices. The consumables and accessories segment is subsegmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas and other consumables and accessories. In 2015, therapeutic devices accounted for the largest share of the global market. The rising incidence of chronic diseases and growing geriatric population contributes to their largest share in the market.

    Based on disease/disorder, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other diseases/disorders. The other diseases/disorders segment includes lung cancer, pulmonary fibrosis, pulmonary embolism, cystic fibrosis, and allergies. In 2015, COPD accounted for the largest share of the global market, by disease/disorder. The factors contributing to the growth of this technology segment includes increasing tobacco smoking prevalence and rising pollution levels globally.

    Furthermore, on the basis of end users, the market is classified into hospitals, home care and ambulatory care. The hospitals companies segment accounted for the largest share in the global respiratory care devices market, by end users. The factors contributing to the growth of this end user segment includes the financial capabilities of hospitals to purchase high-priced instruments as well as the availability of trained professionals in hospitals to operate respiratory care devices.

    Request free sample @ https://www.researchcosmos.com/request/4388298

    In 2015, North America accounted for the largest share of the global respiratory care devices market, followed by Europe, Asia-Pacific, and RoW. Factors such as the rising geriatric population, the presence of a well-established healthcare industry, availability of life sciences and medical research funding, growing demand for point-of-care diagnostic testing, and increasing government healthcare expenditure attribute for the growth of this market in the developed markets in North American and Europe. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, low labor costs, favorable regulatory environment and expansion of private-sector hospitals to rural areas in various APAC and Latin American countries are some factors that will fuel the growth of respiratory care devices market in APAC and Latin America.

    The major players in the respiratory care devices market are Philips Healthcare (The Netherlands), ResMed Inc. (U.S.), Medtronic plc (Ireland), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), Becton, Dickinson and Company (U.S.), Chart Industries, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

    Check for discount @ https://www.researchcosmos.com/discount/4388298

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global restorative dentistry market is projected to reach USD 21.27 Billion by 2022 from USD 15.60 Billion in 2017, at a CAGR of 6.4% during the forecast period. Increase in the prevalence of dental diseases (dental caries and edentulism), rising demand for advanced cosmetic dental procedures, growing dental tourism, and increasing dental expenditure are the major factors driving the demand for restorative dentistry. Moreover, the gradual shift towards newer technologies & products and growing focus of companies in emerging markets is expected to offer significant growth opportunities for players in this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-restorative-dentistry-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/5497126

    The report analyzes the global restorative dentistry market by product, end user, and region. Based on product, the global restorative dentistry market is segmented into restorative materials, implants, prosthetics, and restorative equipment. In 2016, the restorative materials segment accounted for the largest share of global restorative dentistry market, mainly due to the growing number of tooth repair procedures, high cost of restorative materials, increasing adoption of customized prosthetics, and increasing demand for cosmetic dentistry.

    Based on end user, the restorative dentistry market is segmented into hospitals & clinics, dental schools & research institutes, and dental laboratories. The hospitals & clinics segment accounted for the major share of the global restorative dentistry market and is expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics and hospitals especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.

    Request free sample @ https://www.researchcosmos.com/request/5497126

    Geographically, the global restorative dentistry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe holds the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period. The growth of this segment can be attributed to the rising geriatric population, growing dental tourism in major Asian markets, increasing focus of prominent players on emerging Asian countries, increasing healthcare expenditure (coupled with the rising disposable income), rising awareness on oral healthcare, and increasing willingness of people to spend more on dental care to maintain dental aesthetics in the region.

    However, limited reimbursement for dental care may hinder the growth of this market to a certain extent. Furthermore, pricing pressure faced by prominent market players presents a major challenge for the growth of the global restorative dentistry market.

    The global restorative dentistry market is characterized by a large number of players. The prominent players of this market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany).

    Check for discount @ https://www.researchcosmos.com/discount/5497126

    These companies are pursuing several organic and inorganic growth strategies such as mergers, acquisitions, partnerships, agreements, expansions, and product launches.

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The single-cell analysis market is expected to reach USD 3.59 Billion by 2022 from USD 1.67 Billion in 2017, at a CAGR of 16.5%. Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market. The report segments the market into product, cell type, technique, application, end user, and regions.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-single-cell-analysis-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/3094123

    On the basis of product, the market is segmented into consumables and instruments. In 2017, the consumables segment is expected to account for the largest share of the single-cell analysis market. This segment is also expected to register the highest CAGR during the forecast period. The growth of this segment is attributed to the requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

    The single-cell analysis market, by cell type is segmented into human, animal, and microbial cells. In 2017, human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and rising incidence of diseases such as cancer are the major factors driving the growth of this segment.

    Based on the technique, the market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to account for the largest share of the single-cell analysis market. The large share of the flow cytometry segment can primarily be attributed to the wide usage of flow cytometry in single-cell analysis applications.

    The single cell analysis market, by application is segmented into research and medical application. The research applications segment includes cancer, immunology, neurology, stem cell research, and other research applications. While, the medical applications segment includes non-invasive prenatal diagnosis (NIPD), in vitro fertilization (IVF), and circulating tumor cell detection. In 2017, research application is expected to account for the largest share of the single-cell analysis market primarily due to the widespread use of single-cell analysis in cancer research.

    Request free sample @ https://www.researchcosmos.com/request/3094123

    On the basis of end user, the market is segmented into academic & research laboratories, hospitals & diagnostic laboratories, cell banks & IVF centers, and biotechnology & pharmaceutical companies. In 2017, academic and research laboratories form the largest and the fastest growing end-user segment in the single-cell analysis market. The large share and high growth of this segment is attributed to the growth in funding for life science research.

    The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). However, the market in Asia is expected to register the highest CAGR during the forecast period. The large population in China and India, rising geriatric population, and increasing incidence of chronic diseases are the major factors driving the growth of the Asian market.

    The single-cell analysis market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).

    Check for discount @ https://www.researchcosmos.com/discount/3094123

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global single-use bioreactors market is projected to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017, at a CAGR of 21.9%. Single-use bioprocessing, which emerged in the 1970s with the use of vials and pipettes, has transformed significantly over the last decade. Single-use bioprocessing is a rapidly evolving technology used in the development of disposable bioprocessing equipment and accessories to manufacture biopharmaceutical products. These disposable equipment mainly help to reduce costs associated with the sterilization, cleaning, and maintenance of steel-based bioreactor systems and accessories. Increasing adoption of SUBs among small companies and startups and reduced automation complexity are the major factors driving the adoption of single-use bioreactors.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-single-use-bioreactors-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/5265606

    In this report, the global single-use bioreactors market is segmented on the basis of product, type, type of cell, type of molecule, application, end user, and region. Based on product, the single-use bioreactors market is segmented into single-use bioreactor systems, media bags, and filtration assemblies. In 2017, the single-use bioreactor systems segment is expected to account for the largest share of the market. The numerous advantages such as the elimination of validation issues, shortened downtime and turnaround time, and lowered risk of cross-contamination due to the use of new bags for each run has resulted in the increase in the adoption of single-use systems by biopharmaceutical companies.

    On the basis of type of molecule, the global single-use bioreactors market is divided mAbs, vaccines, stem cells, gene-modified cells, and other molecules. In 2017, the mAbs segment is expected to account for the largest share of the market. For manufacturing mAbs, mammalian cells are increasingly being employed to successfully impart dynamic therapeutic mechanism of action. The commercial success of mammalian cell-derived mAbs has led to an increase in the demand for novel SUB systems that provide greater productivity and flexibility and reduced costs.

    Request free sample @ https://www.researchcosmos.com/request/5265606

    In 2017, in terms of value, Europe is expected to account for the largest share of the global single-use bioreactors market. North America region is expected to register the highest growth rate from 2017 to 2022.

    The fear of losing visibility & control over business processes and reliability and data security & privacy concerns are the major factors expected to restrain market growth.

    The key players in the single-use bioreactors market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the single-use bioreactors market.

    Check for discount @ https://www.researchcosmos.com/discount/5265606

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global sports medicine market is projected to reach USD 8.24 Billion by 2022 from USD 5.78 Billion in 2017, at a CAGR of 7.4% during the forecast period. The increasing incidence of sports injuries, continuous influx of new products and treatment modalities, and developments in the field of regenerative medicine are some of the major factors driving the growth of the global sports medicine market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-sports-medicine-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/8757455

    The sports medicine market is segmented on the basis of product, application, and region. On the basis of product, the global market is segmented into body reconstruction products, body support & recovery products, and accessories. The body reconstruction products segment is further categorized into implants, fracture & ligament repair devices, arthroscopy devices, prosthetics, and orthobiologics. The orthobiologics segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment can be attributed to the recent developments in regenerative medicine, allografts, and stem cell therapy.

    The body support & recovery products segment is further divided into braces and supports, compression clothing, and physiotherapy equipment. The physiotherapy equipment segment is further categorized into thermal therapy, electrostimulation, and other therapies.

    Based on application, the market is segmented into shoulder, foot and ankle, elbow & wrist, back & spine, hip & groin, knee, and other injuries (head, face, and finger injuries). In 2017, the knee injuries segment is estimated to command the largest share of the sports medicine market. Growth in the knee injuries segment can be attributed to the increasing participation in sports like football and basketball at a younger age, resulting in high prevalence of knee injuries.

    Request free sample @ https://www.researchcosmos.com/request/8757455

    The elbow and wrist injuries segment is estimated to register the highest CAGR during to forecast period. This can be attributed to the increasing number of injuries in sports, like rowing, racquet sports, and golf, where there is a repetitive overuse of elbow and wrists.

    The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American region is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increased popularity of sports & physical activities, continued government support, investments in the field of sports awareness, and efforts to raise awareness on the prevention & treatment of sports injuries.

    The high costs of orthopedic implants and other devices are restraining the growth of the market.

    The major players in this market include Arthrex, (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), CONMED (US), Zimmer Biomet (US), Breg (US), DJO Global (US), Mueller Sports (US), Wright Medical Group (US), Medtronic (Ireland), RTI Surgical (US), and Performance Health International (US).

    Check for discount @ https://www.researchcosmos.com/discount/8757455

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

older | 1 | .... | 1025 | 1026 | (Page 1027) | 1028 | 1029 | .... | 1118 | newer